Sage Therapeutics, Inc. Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sage Therapeutics, Inc. for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,240 | 27.3 K to 49.2 K (+80.17 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
| Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 65.34 | 1,300 | 84,942 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 67.14 | 1,220 | 81,911 | 1,300 | 2.5 K to 1.3 K (-48.41 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Sell | S | 67.66 | 3,480 | 235,457 | 2,520 | 6 K to 2.5 K (-58.00 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 65.88 | 338 | 22,267 | 87,563 | 87.9 K to 87.6 K (-0.38 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 67.20 | 900 | 60,480 | 87,901 | 88.8 K to 87.9 K (-1.01 %) |
| Aug 11 2015 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 67.95 | 2,762 | 187,678 | 88,801 | 91.6 K to 88.8 K (-3.02 %) |
| Aug 04 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 67.06 | 12,000 | 804,720 | 182,222 | 194.2 K to 182.2 K (-6.18 %) |
| Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 66.42 | 6,020 | 399,848 | 703,650 | 709.7 K to 703.7 K (-0.85 %) | |
| Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 67.05 | 9,158 | 614,044 | 709,670 | 718.8 K to 709.7 K (-1.27 %) | |
| Aug 04 2015 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 67.98 | 4,822 | 327,800 | 718,828 | 723.7 K to 718.8 K (-0.67 %) |